(Q24199115)

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Tolerance and safety evaluation in a large cohort of healthy infants fed an innovative prebiotic formula: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

A mixture of three prebiotics does not affect vaccine specific antibody responses in healthy term infants in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Do prebiotics reduce the number of fever episodes in healthy children in their first year of life: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Design of a randomised controlled trial on immune effects of acidic and neutral oligosaccharides in the nutrition of preterm infants: carrot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo- and acidic oligosaccharides on intestinal permeability in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Exploration of basal immune parameters in healthy infants receiving an infant milk formula supplemented with prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Faecal SIgA secretion in infants fed on pre- or probiotic infant formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

The effect of prebiotics in the management of neonatal hyperbilirubinaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Molecular ecological analysis of fecal bacterial populations from term infants fed formula supplemented with selected blends of prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Long-term colonization of a Lactobacillus plantarum synbiotic preparation in the neonatal gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

The effects of lactulose supplementation to enteral feedings in premature infants: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Neurodevelopmental outcomes of very low-birth-weight infants after enteral glutamine supplementation in the neonatal period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Cytokine profiles in 1-yr-old very low-birth-weight infants after enteral glutamine supplementation in the neonatal period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

The effect of glutamine-enriched enteral nutrition on intestinal permeability in very-low-birth-weight infants: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

A randomized controlled trial of enteral glutamine supplementation in very low birth weight infants: plasma amino acid concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Glutamine-enriched enteral nutrition in very low birth weight infants. Design of a double-blind randomised controlled trial [ISRCTN73254583]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Cytokine responses in very low birth weight infants receiving glutamine-enriched enteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

The effect of glutamine-enriched enteral nutrition on intestinal microflora in very low birth weight infants: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Glutamine-enriched enteral nutrition in very low-birth-weight infants: effect on the incidence of allergic and infectious diseases in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Physiological and bifidogenic effects of prebiotic supplements in infant formulae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

World Allergy Organization guidelines for prevention of allergy and allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Allergy development and the intestinal microflora during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Changes in asthma prevalence: two surveys 15 years apart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Atopic versus infectious diseases in childhood: a question of balance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Maternal smoking in pregnancy, fetal development, and childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Probiotics in infants for prevention of allergic disease and food hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

The prevalence of food hypersensitivity in an unselected population of children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Low-normal gestational age as a predictor of asthma at 6 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

21 January 2018

Update on food allergy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Atopic dermatitis: an increasing problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Prebiotic supplementation of formula in preterm neonates: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Prebiotics in infants for prevention of allergic disease and food hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Advances in the management of digestive problems during the first months of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Reduction of crying episodes owing to infantile colic: a randomized controlled study on the efficacy of a new infant formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

Bifidogenic Effects of Solid Weaning Foods With Added Prebiotic Oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Dietary prebiotic oligosaccharides are detectable in the faeces of formula-fed infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Glutamine-enriched enteral nutrition in very-low-birth-weight infants and effects on feeding tolerance and infectious morbidity: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity--a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Dietary nucleotides and fecal microbiota in formula-fed infants: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Term infants fed formula supplemented with selected blends of prebiotics grow normally and have soft stools similar to those reported for breast-fed infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Prebiotics improve gastric motility and gastric electrical activity in preterm newborns

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Pro- and prebiotic supplementation induces a transient reduction in hemoglobin concentration in infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Perinatal characteristics and obstetric complications as risk factors for asthma, allergy and eczema at the age of 6 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Prediction of allergy from family history and cord blood IgE levels. A follow-up at the age of 5 years. Cord blood IgE. IV

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Effect of probiotics on vaccine antibody responses in infancy--a randomized placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Increased activation of GATA-3, IL-2 and IL-5 of cord blood mononuclear cells in infants with IgE sensitization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

High intestinal IgA associates with reduced risk of IgE-associated allergic diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Atopic disease in seven-year-old children. Incidence in relation to family history

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Dietary Nucleotides and Early Growth in Formula-Fed Infants: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

Neutral and acidic oligosaccharides in preterm infants: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

The Australasian Society of Clinical Immunology and Allergy position statement: Summary of allergy prevention in children.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006474.PUB3

7 January 2021

10.1002/14651858.CD006474.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23543544

1 reference

Consolidated OpenCitations Corpus – April 2017